Podstawowe statystyki
| LEI | 5493002KS2T1Q0X7VZ21 |
| CIK | 921582 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to IMAX Corporation
SEC Filings (Chronological Order)
Na tej stronie znajduje się pełna, chronologiczna lista zgłoszeń SEC, z wyłączeniem zgłoszeń własności, które udostępniamy gdzie indziej.
| May 29, 2026 |
IMAX CORPORATION Conflict Minerals Report For the Year Ended December 31, 2025 EX-1.01 Exhibit 1.01 IMAX CORPORATION Conflict Minerals Report For the Year Ended December 31, 2025 This report for the year ended December 31, 2025, is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). The Rule was adopted by the Securities and Exchange Commission (the “SEC”) to implement reporting and disclosure requirements related to conflict minerals |
|
| May 29, 2026 |
SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT IMAX Corporation (Exact name of the registrant as specified in its charter) Canada 001-35066 98-0140269 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 2525 Speakman Drive, 902 Broadway, Floor 20 Mississauga, ON, |
|
| April 30, 2026 |
IMAX CORPORATION REPORTS FIRST QUARTER 2026 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS FIRST QUARTER 2026 RESULTS •IMAX reaffirms 2026 full-year guidance, including $1.4 billion in global box office — driven by a strong, diverse upcoming slate including Christopher Nolan’s The Odyssey, Dune: Part Three, The Mandalorian and Grogu, and Narnia among at least 14 Filmed For IMAX releases •Bottom-line growth year-over-year underscores strong operating |
|
| April 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpo |
|
| April 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 30, 2026 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 24, 2026 |
F For UNITEDSTATESSECURITIESANDEXCHANGECOMMISSION WASHINGTON,D.C.20549 Form10-K (MarkOne) ☒ ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 ForthefiscalyearendedDecember31,2025 ☐ TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Forthetransitionperiodfromto CommissionfileNumber001-35066 IMAXCorporation (Exactnameofregistrantasspecifiedinitscharter) C |
|
| April 24, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X ] Definitive |
|
| April 17, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 16, 2026 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 March 30, 2026 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 30, 2026 |
IMAX Corporation Announces CEO Richard Gelfond Taking Temporary Medical Leave of Absence Exhibit 99.1 IMAX Corporation Announces CEO Richard Gelfond Taking Temporary Medical Leave of Absence NEW YORK — March 30, 2026 — IMAX Corporation (NYSE: IMAX) today announced CEO Richard Gelfond is on a temporary medical leave of absence as he undergoes treatment for pneumonia. He is receiving outstanding care and progressing in his recovery. While he receives medical care and recovers, Mr. Gelfo |
|
| February 25, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 February 25, 2026 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| February 25, 2026 |
IMAX CORPORATION POWER OF ATTORNEY IMAX CORPORATION EXHIBIT 24.1 POWER OF ATTORNEY Each of the persons whose signature appears below hereby constitutes and appoints Natasha Fernandes and Robert D. Lister, and each of them severally, as his true and lawful attorney or attorneys with power of substitution and re-substitution to sign in his name, place and stead in any and all such capacities the Form 10-K, including the French langua |
|
| February 25, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K For UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file Number 001-35066 IMAX Corporati |
|
| February 25, 2026 |
Three Months Ended December 31, Exhibit 99.1 IMAX CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS •IMAX delivers above expectations for full year 2025 across key metrics: ◦Best-ever Revenue of $410 million, up 16% year-over-year ◦Strong operating profitability with Net Income margin of 11% and record Adjusted EBITDA(1) margin of 45% ◦Record Cash from Operating Activities of $127 million, up 79% year-over-year •High |
|
| February 25, 2026 |
IMAX CORPORATION SUBSIDIARIES OF IMAX CORPORATION IMAX CORPORATION Exhibit 21.1 SUBSIDIARIES OF IMAX CORPORATION Company Name Place of Incorporation 12582 Productions Inc. Delaware 1329507 Ontario Inc. Ontario 2328764 Ontario Ltd. Ontario 3183 Films Ltd. Canada 4507592 Canada Ltd. Canada 6822967 Canada Ltd. Canada 7096267 Canada Ltd. (formerly 3D Sea II Ltd.) Canada 7103077 Canada Ltd. Canada 7109857 Canada Ltd. Canada 7214316 Canada Ltd. Canada |
|
| November 6, 2025 |
IMAX Corporation Announces Closing of $250 Million Convertible Senior Notes Offering EX-99.3 Exhibit 99.3 IMAX Corporation Announces Closing of $250 Million Convertible Senior Notes Offering • Issued $250 million of 0.75% convertible senior notes due 2030; proceeds used to retire substantially all of the outstanding 2026 notes • $57.10 price under capped call transaction, which represents an approximately 75% premium to current stock price NEW YORK, NY — November 6, 2025 — IMAX Co |
|
| November 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 November 3, 2025 Date of report (Date of earliest event reported): IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 6, 2025 |
IMAX Corporation Prices $220 Million Convertible Senior Notes Offering EX-99.2 Exhibit 99.2 IMAX Corporation Prices $220 Million Convertible Senior Notes Offering • Opportunistic capital raise for the substantial refinancing of outstanding 2026 notes • IMAX to purchase capped calls intended to offset any share dilution until a 75% premium to the last reported sale price of IMAX’s common shares on the date of pricing New York—November 3, 2025—IMAX Corporation (NYSE: I |
|
| November 6, 2025 |
IMAX Corporation Announces Proposed Convertible Senior Notes Offering EX-99.1 Exhibit 99.1 IMAX Corporation Announces Proposed Convertible Senior Notes Offering • Opportunistic capital raise for the partial refinancing of outstanding 2026 notes, working capital, share repurchases or other general corporate purposes • IMAX to purchase capped calls intended to offset any share dilution until at least a targeted 75% premium to the last reported sale price of IMAX’s com |
|
| November 6, 2025 |
EX-4.2 Exhibit 4.2 THIS IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS THE OWNER AND HOLDER OF THIS NOTE FOR ALL PURPOSES. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST |
|
| November 6, 2025 |
EX-4.1 Exhibit 4.1 IMAX CORPORATION and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of November 6, 2025 0.750% Convertible Senior Notes due 2030 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction 1 Section 1.01. Definitions 1 Section 1.02. Other Definitions 13 Section 1.03. Rules of Construction 14 Article 2. The Notes 15 Section 2.01. Form, Dating |
|
| November 6, 2025 |
[Signature Page to [Base][Additional] Capped Call Confirmation] EX-10.1 Exhibit 10.1 [Dealer name and address] November [], 2025 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Chief Financial Officer Telephone No.: (905) 403-6457 Email: [email protected]; [email protected] Re: [Base][Additional] Call Option Transaction The purpose of this letter agreement (this “Confirmation”) is to confirm the terms |
|
| October 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 October 23, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 23, 2025 |
Three Months Ended September 30, Exhibit 99.1 IMAX CORPORATION REPORTS THIRD QUARTER 2025 RESULTS •IMAX delivers record Q3 financial results across key metrics: ◦Record third quarter Revenue of $106.7 million ◦More than 30% YoY growth in Net Income, Adjusted EBITDA(1), EPS and Adjusted EPS(1) ◦Strong profitability with Net Income Margin of 21% and Adjusted EBITDA(1) margin of 49% ◦Record quarterly cash flow of $67.5 million in Ca |
|
| October 23, 2025 |
THIRD AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.2 THIRD AMENDMENT TO EMPLOYMENT AGREEMENT This agreement (this "Third Amendment") amends, effective as of January 1, 2026 (the Effective Date"), the employment agreement between Richard L. Gelfond (the "Executive") and IMAX Corporation (the "Company"), dated November 8, 2016, as previously amended effective January 1, 2020 (the “First Amendment”) and January 1, 2023 (the “Second Amendme |
|
| October 23, 2025 |
Exhibit 3.1 SCHEDULE I 1 Common Shares The rights, privileges, restrictions and conditions attaching to the Common Shares are as follows: (a) Payment of Dividends: The holders of the Common Shares shall be entitled to receive dividends if, as and when declared by the Board of Directors of the Corporation out of the assets of the Corporation properly applicable to the payment of dividends in such a |
|
| October 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX C |
|
| October 23, 2025 |
Exhibit 10.1 SEVENTH AMENDED AND RESTATED CREDIT AGREEMENT by and among IMAX CORPORATION, as Borrower - and - THE GUARANTORS REFERRED TO HEREIN, as Guarantors - and - THE LENDERS REFERRED TO HEREIN, as Lenders - and - WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, Issuing Lender and Swingline Lender - and - WELLS FARGO SECURITIES, LLC, as Sole Lead Arranger - and - WELLS FARGO SE |
|
| September 15, 2025 |
144 0001255900 XXXXXXXX LIVE 0000921582 IMAX Corp 001-35066 902 Broadway FL 20 New York NY 10010 2128210142 Robert D. |
|
| July 24, 2025 |
Amendment to Employment Terms, dated as of May 20, 2025, between IMAX Corporation and Exhibit 10.6 Amendment to Employment Terms This agreement (this “Amendment”) amends, effective as of June 1, 2025, the terms and conditions of your employment (the “Employment Terms”) with IMAX Corporation (the “Company”). Except as otherwise expressly set forth below in this Amendment, all other Employment Terms with the Company will remain the same. WHEREAS, the Company wishes to remove the prov |
|
| July 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpor |
|
| July 24, 2025 |
Amendment to Employment Terms, dated as of May 20, 2025, between IMAX Corporation and Jose Zlatar Exhibit 10.3 Amendment to Employment Terms This agreement (this “Amendment”) amends, effective as of June 1, 2025, the terms and conditions of your employment (the “Employment Terms”) with IMAX Corporation (the “Company”). Except as otherwise expressly set forth below in this Amendment, all other Employment Terms with the Company will remain the same. WHEREAS, the Company wishes to remove the prov |
|
| July 24, 2025 |
, dated as of March 13, 2025, between IMAX Corporation and Jose Zlatar Exhibit 10.1 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. March 13, 2025 Revised, Strictly Private & Confidential Jose Zlatar [***] Dear Jose, This employment agreement (the “Agreement”) will confirm our offer to you to join |
|
| July 24, 2025 |
Amendment to Employment Terms, dated as of May 20, 2025, between IMAX Corporation and Exhibit 10.5 Amendment to Employment Terms This agreement (this "Amendment") amends, effective as of June 1, 2025, the terms and conditions of your employment agreement dated September 18, 2020, as amended on October 13, 2021 (the "Employment Agreement") with IMAX Corporation (the "Company"). Except as otherwise expressly set forth below in this Amendment, all other Employment Terms with the Compa |
|
| July 24, 2025 |
0, 2025, between IMAX Corporation and Anne Globe Exhibit 10.4 Amendment to Employment Terms This agreement (this “Amendment”) amends, effective as of June 1, 2025, the terms and conditions of your employment (the “Employment Terms”) with IMAX Corporation (the “Company”). Except as otherwise expressly set forth below in this Amendment, all other Employment Terms with the Company will remain the same. WHEREAS, the Company wishes to remove the prov |
|
| July 24, 2025 |
Employment Agreement, dated as of January 12, 2024, between IMAX Corporation and Exhibit 10.2 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. January 12, 2024 Strictly Private & Confidential Anne Globe [***] Dear Anne, We are excited about the prospect of your joining us at IMAX. The terms and conditions of |
|
| July 24, 2025 |
Exhibit 99.1 IMAX CORPORATION REPORTS Q2 RESULTS •Growth in network sales and installations and box office combine to deliver strong financial results for global entertainment technology platform, including over 25% YoY increase in Net Income, Adjusted EBITDA(1), EPS and Adjusted EPS(1) •Increasing demand for IMAX drives network growth momentum with 36 system installations in Q2 (+50% YoY) and 123 |
|
| July 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 24, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 17, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 14, 2025 Date of report (Date of earliest event reported): IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| June 13, 2025 |
IMAX Announces $100 Million Increase to Current Share-Repurchase Program Exhibit 99.1 IMAX Announces $100 Million Increase to Current Share-Repurchase Program NEW YORK, NY— June 12, 2025 – IMAX Corporation (NYSE: IMAX) today announced an increase of $100 million in the Company’s share repurchase program along with a one-year extension through June 30, 2027. This expansion brings the Company’s total share repurchase authorization to $500 million, of which approximately |
|
| June 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 June 11, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT IMAX Corporation (Exact name of the registrant as specified in its charter) Canada 001-35066 98-0140269 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 2525 Speakman Drive, 902 Broadway, Floor 20 Mississauga, ON, Can |
|
| May 30, 2025 |
Conflict Minerals Report for the year ended December 31, 2024. Exhibit 1.01 IMAX CORPORATION Conflict Minerals Report For the Year Ended December 31, 2024 This report for the year ended December 31, 2024 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). The Rule was adopted by the Securities and Exchange Commission (the “SEC”) to implement reporting and disclosure requirements related to conflict minerals as direct |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 23, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 25, 2025 |
+$ *)**))+( * )$. $ %## )) %$ -) $ *%$ ?B= ! #1B;%>5 $$+"(&%(*&+()+$**%)* %$ %( 4% * )+( * ) . $ *% ?BD8569C31<I51B5>454535=25B *($) * %$(&%(*&+()+$**%)* %$ %( 4% * )+( * ). $ *% ?BD85DB1>C9D9?>@5B9?46B?=0000D?0000 ?==9CC9?>69<5$E=25B #.?B@?B |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X ] Definitive |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpo |
|
| April 23, 2025 |
IMAX CORPORATION REPORTS FIRST QUARTER 2025 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS FIRST QUARTER 2025 RESULTS •Global entertainment platform delivers strong start to 2025 including Q1 Revenues of $87 million (+10% YoY), Net Income of $8 million (+52% YoY) at a 9% margin and Total Adjusted EBITDA(1) of $37 million (+15% YoY) at a 43% margin. •Demand for The IMAX Experience® is accelerating with significant systems growth in Q1 driven by syste |
|
| April 23, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 23, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 23, 2025 |
Exhibit 10.1 AMENDMENT AGREEMENT TO EMPLOYMENT AGREEMENT This AMENDMENT AGREEMENT to the EMPLOYMENT AGREEMENT is dated as of March 7, 2025, with effect from January 1, 2025 (the “Agreement”) between IMAX CHINA (HONG KONG) LIMITED (the “Company”) and DANIEL WADE MANWARING (the “Executive”). WHEREAS, the Company and the Executive have entered into an employment agreement dated as of January 9, 2023, |
|
| February 19, 2025 |
IMAX CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS •Global entertainment platform delivers Q4 Net Income of $5 million (+112% YoY), at a 5.7% margin, EPS(1) of 10 cents (+100% YoY), Adjusted EPS of 27 cents (+59% YoY) and Total Adjusted EBITDA(2) of $37 million (+48% YoY) at a 40% margin. •Full-Year Net Income of $26 million (+3% YoY) at a 7.4% margin, Total Adjusted E |
|
| February 19, 2025 |
Exhibit 19.1 Insider Trading Policy Updated August 2024 IMAX CORPORATION Insider Trading Policy 1.Purpose The securities laws of the United States and Canada prohibit “insider trading” and impose restrictions on trading in securities while in possession of material non-public information. The guidelines described in this Insider Trading Policy (the “Policy”) have been developed to assist IMAX Corp |
|
| February 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file Number 001-35066 |
|
| February 19, 2025 |
IMAX CORPORATION SUBSIDIARIES OF IMAX CORPORATION IMAX CORPORATION Exhibit 21.10 SUBSIDIARIES OF IMAX CORPORATION Company Name Place of Incorporation 3183 Films Ltd. Canada 12582 Productions Inc. Delaware 1329507 Ontario Inc. Ontario 2328764 Ontario Ltd. Ontario 4507592 Canada Ltd. Canada 6822967 Canada Ltd. Canada 7096267 Canada Ltd. Canada 7103077 Canada Ltd. Canada 7109857 Canada Ltd. Canada 7214316 Canada Ltd. Canada 7550391 Canada Ltd. Canad |
|
| February 19, 2025 |
IMAX CORPORATION POWER OF ATTORNEY IMAX CORPORATION EXHIBIT 24.1 POWER OF ATTORNEY Each of the persons whose signature appears below hereby constitutes and appoints Natasha Fernandes and Robert D. Lister, and each of them severally, as his true and lawful attorney or attorneys with power of substitution and re-substitution to sign in his name, place and stead in any and all such capacities the Form 10-K, including the French langua |
|
| February 19, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 February 19, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| February 12, 2025 |
EX-99 2 exhibit99.txt Exhibit 99 Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management |
|
| January 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 January 17, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| November 14, 2024 |
SC 13G 1 imax111424.htm ORBIS INVESTMENT MANAGEMENT LIMITED UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 IMAX CORP (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 45245E109 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to |
|
| November 12, 2024 |
IMAX / IMAX Corporation / FMR LLC Passive Investment SC 13G 1 filing.txt SCHEDULE 13G Amendment No.0 IMAX CORPORATION COMMON STOCK Cusip #45245E109 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #45245E109 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 3,892,586 Item 6: 0 Item 7: 3,910,242 Item 8: 0 Item 9: 3,91 |
|
| November 12, 2024 |
IMAX / IMAX Corporation / BlackRock, Inc. Passive Investment SC 13G/A 1 ca45245e1097111224.txt ca45245e1097111224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) IMAX CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 2473859 - (SEDOL Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| November 1, 2024 |
IMAX / IMAX Corporation / MACQUARIE GROUP LTD - SC 13G/A Passive Investment SC 13G/A 1 d899073dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Imax Corp (Name of Issuer) Common Shares (Title of Class of Securities) 45245E109 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| November 1, 2024 |
EX-99.B 3 d899073dex99b.htm EX-99.B EXHIBIT B Powers of Attorney for Macquarie Group Limited incorporated by reference to 13G filings made by Macquarie Group Limited on June 7, 2023. Page 13 of 13 |
|
| November 1, 2024 |
EX-99.A 2 d899073dex99a.htm EX-99.A EXHIBIT A AGREEMENT TO FILE JOINT ACQUISITION STATEMENTS AGREEMENT made this [7th] day of FEBRUARY, 2024 by and between Delaware Funds by Macquarie,® Optimum Fund Trust and Macquarie ETF Trust listed on Annex A hereto, Macquarie Investment Management Business Trust, Macquarie Management Holdings, Inc, and the Macquarie Parties listed on Annex B hereto (collectiv |
|
| October 30, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 October 30, 2024 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX C |
|
| October 30, 2024 |
IMAX CORPORATION REPORTS THIRD QUARTER 2024 EARNINGS RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS THIRD QUARTER 2024 EARNINGS RESULTS •Global entertainment platform delivers Net Income of $14 million (+16% YoY), EPS(1) of 26 cents (+18% YoY), and Cash from Operations of $35 million (+23% YoY) •Strong profitability highlighted by Total Adjusted EBITDA(2) of $39 million at a 42% margin; and Adjusted EPS(1)(2) of 35 cents, matching a third quarter record •Net |
|
| October 18, 2024 |
IMAX / IMAX Corporation / BlackRock, Inc. Passive Investment SC 13G 1 ca45245e1097101824.txt ca45245e1097101824.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) IMAX CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 2473859 - (SEDOL Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 September 11, 2024 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| July 25, 2024 |
IMAX CORPORATION REPORTS SECOND QUARTER 2024 EARNINGS RESULTS EX-99.1 2 imax-q22024epr.htm EX-99.1 Exhibit 99.1 IMAX CORPORATION REPORTS SECOND QUARTER 2024 EARNINGS RESULTS •Global entertainment platform delivers solid results, including Revenue of $89 million, Net Income of $3.6 million, EPS(1) of 7 cents, Total Adjusted EBITDA(2) of $31 million and Adjusted EPS(1) of 18 cents. •Signings for new and upgraded IMAX systems grow to 87 (+89%) in the quarter; s |
|
| July 25, 2024 |
Amendment Agreement to Employment Agreement, dated as of March 7, 2024, between IMAX Exhibit 10.2 AMENDMENT AGREEMENT TO EMPLOYMENT AGREEMENT This AMENDMENT AGREEMENT to the EMPLOYMENT AGREEMENT is dated as of March 7, 2024, with effect from January 1, 2024 (the “Agreement”) between IMAX CHINA (HONG KONG) LIMITED (the “Company”) and DANIEL WADE MANWARING (the “Executive”). WHEREAS, the Company and the Executive have entered into an employment agreement dated as of January 9, 2023 |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 25, 2024 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpor |
|
| July 25, 2024 |
Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT is dated as of January 9, 2023 (the “Agreement”) between IMAX CHINA (HONG KONG) LIMITED (the “Company”) and DANIEL WADE MANWARING (the “Executive”). WHEREAS, the Company wishes to employ the Executive and the Executive wishes to be employed by the Company; and WHEREAS, the Company and the Executive have agreed to formalize the terms and c |
|
| June 17, 2024 |
EX-7.2 3 d807372dex72.htm EX-7.2 Exhibit 7.2 LIMITED POWER OF ATTORNEY FOR REPORTING OBLIGATIONS UNDER SECTIONS 13(D) AND 13(G) OF THE SECURITIES EXCHANGE ACT OF 1934 The undersigned hereby make, constitute and appoint each of Eileen Wheatman and Kevin Douglas, acting either individually or together, as each of the undersigned’s true and lawful attorneys-in-fact, with full power and authority as h |
|
| June 17, 2024 |
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D EX-7.1 2 d807372dex71.htm EX-7.1 Exhibit 7.1 AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D Each of the undersigned hereby acknowledges and agrees, pursuant to the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13D to which this Agreement is attached as an Exhibit, and any amendments thereto, with respect to the be |
|
| June 17, 2024 |
IMAX / IMAX Corporation / DOUGLAS KEVIN - SC 13D/A Activist Investment SC 13D/A 1 d807372dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9) IMAX Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 45245E109 (CUSIP Number) Ryan J. York Accretive Legal, PLLC 34522 N. Scottsdale Rd. STE 120-113 Scottsdale, AZ 85266 (425) 786-9256 (Name, |
|
| June 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 June 6, 2024 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT IMAX Corporation (Exact name of the registrant as specified in its charter) Canada 001-35066 98-0140269 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 2525 Speakman Drive, 902 Broadway, Floor 20 Mississauga, ON, Can |
|
| May 31, 2024 |
Conflict Minerals Report for the year ended December 31, 2023. Exhibit 1.01 IMAX CORPORATION Conflict Minerals Report For the Year Ended December 31, 2023 This report for the year ended December 31, 2023 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). The Rule was adopted by the Securities and Exchange Commission (the “SEC”) to implement reporting and disclosure requirements related to conflict minerals as direct |
|
| April 26, 2024 |
1Q1+ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file Number 001-35066 IMAX Corporation (Exact name of registrant as s |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X ] Definitive |
|
| April 25, 2024 |
IMAX CORPORATION REPORTS FIRST QUARTER 2024 EARNINGS RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS FIRST QUARTER 2024 EARNINGS RESULTS • Global entertainment platform delivers Revenue of $79 million and strong profitability, including Net Income of $3.3 million up 33% YoY and Total Adjusted EBITDA Margin(1) of 40.5% up more than 300 basis points YoY. • IMAX system installations climb +67% YoY to 15 in Q1; sales activity gaining momentum with 17 signings for |
|
| April 25, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 25, 2024 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpo |
|
| April 17, 2024 |
United States securities and exchange commission logo April 17, 2024 Natasha Fernandes Chief Financial Officer IMAX CORP 902 Broadway, Floor 20 New York, NY 10010 Re: IMAX CORP Form 10-K for Fiscal Year Ended December 31, 2023 color:white;" File No. |
|
| April 16, 2024 |
IMAX Corporation | 902 Broadway, 20th Floor, New York, NY 10010 | 212-821-0100 | Fax: 212-821-0105 Ms. Nudrat Salik Mr. Terence O’Brien United States Securities and Exchange Commission Office of Industrial Applications and Services Division of Corporation Finance 100 F Street, NE Mail Stop 3030 Washington, D.C. 20549 April 16, 2024 Re: IMAX CORP (“IMAX” or “the Company”) Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-35066 Dear Ms. Salik and Mr. O’Brien, We are writing in respon |
|
| March 20, 2024 |
United States securities and exchange commission logo March 20, 2024 Natasha Fernandes Chief Financial Officer IMAX CORP 902 Broadway, Floor 20 New York, NY 10010 Re: IMAX CORP Form 10-K for Fiscal Year Ended December 31, 2023 color:white;" File No. |
|
| March 12, 2024 |
IMAX Corporation | 902 Broadway, 20th Floor, New York, NY 10010 | 212-821-0100 | Fax: 212-821-0105 Ms. Nudrat Salik Mr. Terence O’Brien United States Securities and Exchange Commission Office of Industrial Applications and Services Division of Corporation Finance 100 F Street, NE Mail Stop 3030 Washington, D.C. 20549 March 12, 2024 Re: IMAX CORP (“IMAX” or “the Company”) Form 10-K for Fiscal Year Ended December 31, 2022 Form 10-Q for Fiscal Quarter Ended September 30, 2023 File No. 001-35066 De |
|
| February 27, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 February 27, 2024 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K 1Q1+ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file Number 001-35066 IMAX Corporation (Exact name of registrant as s |
|
| February 27, 2024 |
IMAX CORPORATION EXHIBIT 10.24 SECOND AMENDING AGREEMENT This Second Amending Agreement, dated as of October 20, 2023 (the “Second Amending Agreement”), is made between IMAX CORPORATION, a corporation organized under the laws of Canada (the “Company”), and ROBERT D. LISTER (the “Executive”). WHEREAS, the Executive currently serves as the Chief Legal Officer and Senior Executive Vice President of t |
|
| February 27, 2024 |
IMAX CORPORATION REPORTS Q4 AND FULL-YEAR 2023 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS Q4 AND FULL-YEAR 2023 RESULTS • Global entertainment technology platform delivers over 25% YoY growth in FY23 across Revenue, Net Income, Adjusted EBITDA(1) and Adjusted EPS(1)(2) • Full-Year GAAP EPS of $0.46, up from a loss of ($0.40) in FY22; Full-Year Adjusted EPS of $0.94, up from $0.06 in FY22 • Net Income of $25 million in FY23 increased from a loss of |
|
| February 27, 2024 |
IMAX CORPORATION EXHIBIT 97.1 IMAX CLAWBACK POLICY The Board of Directors (the “Board”) of IMAX Corporation (the “Company”) has adopted this Clawback Policy (this “Policy”) in accordance with the applicable provisions of The New York Stock Exchange Listed Company Manual (the “Clawback Rules”), promulgated pursuant to the final rules adopted by the Securities and Exchange Commission enacting the cl |
|
| February 27, 2024 |
Power of Attorney of certain directors. IMAX CORPORATION EXHIBIT 24.1 POWER OF ATTORNEY Each of the persons whose signature appears below hereby constitutes and appoints Natasha Fernandes and Robert D. Lister, and each of them severally, as his true and lawful attorney or attorneys with power of substitution and re-substitution to sign in his name, place and stead in any and all such capacities the Form 10-K, including the French langua |
|
| February 27, 2024 |
Subsidiaries of IMAX Corporation. IMAX CORPORATION Exhibit 21.1 SUBSIDIARIES OF IMAX CORPORATION Company Name Place of Incorporation 3183 Films Ltd. Canada 12582 Productions Inc. Delaware 1329507 Ontario Inc. Ontario 2328764 Ontario Ltd. Ontario 4507592 Canada Ltd. Canada 6822967 Canada Ltd. Canada 7096267 Canada Ltd. Canada 7103077 Canada Ltd. Canada 7109857 Canada Ltd. Canada 7214316 Canada Ltd. Canada 7550391 Canada Ltd. Canada |
|
| February 14, 2024 |
EX-99.B 3 d737831dex99b.htm EX-99.B EXHIBIT B Powers of Attorney for Macquarie Group Limited incorporated by reference to 13G filings made by Macquarie Group Limited on June 7, 2023. Page 13 of 13 |
|
| February 14, 2024 |
IMAX / IMAX Corporation / Nantahala Capital Management, LLC - SC 13G/A Passive Investment SC 13G/A 1 tm243309d4sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* IMAX Corporation (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 45245E109 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate |
|
| February 14, 2024 |
EX-99.A 2 d737831dex99a.htm EX-99.A EXHIBIT A AGREEMENT TO FILE JOINT ACQUISITION STATEMENTS AGREEMENT made this [7th] day of FEBRUARY, 2024 by and between Delaware Funds by Macquarie,® Optimum Fund Trust and Macquarie ETF Trust listed on Annex A hereto, Macquarie Investment Management Business Trust, Macquarie Management Holdings, Inc, and the Macquarie Parties listed on Annex B hereto (collectiv |
|
| February 14, 2024 |
IMAX / IMAX Corporation / MACQUARIE GROUP LTD - SC 13G Passive Investment SC 13G 1 d737831dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 0)* Imax Corp (Name of Issuer) Common Shares (Title of Class of Securities) 45245E109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| February 13, 2024 |
United States securities and exchange commission logo February 13, 2024 Natasha Fernandes Chief Financial Officer IMAX CORP 902 Broadway, Floor 20 New York, NY 10010 Re: IMAX CORP Form 10-K for Fiscal Year Ended December 31, 2022 Form 10-Q for Fiscal Quarter Ended September 30, 2023 File No. |
|
| February 9, 2024 |
IMAX / IMAX Corporation / FMR LLC Passive Investment SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.1 IMAX CORPORATION COMMON STOCK Cusip #45245E109 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #45245E109 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 684,237 Item 6: 0 Item 7: 686,159 Item 8: 0 Item 9: 686,15 |
|
| February 7, 2024 |
IMAX / IMAX Corporation / BlackRock Inc. Passive Investment SC 13G/A 1 ca45245e1097020724.txt ca45245e1097020724.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) IMAX CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 2473859 - (SEDOL Number) January 31, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 2, 2024 |
IMAX / IMAX Corporation / BlackRock Inc. Passive Investment ca45245e1097020224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) IMAX CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 2473859 - (SEDOL Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| January 29, 2024 |
IMAX Corporation | 902 Broadway, 20th Floor, New York, NY 10010 | 212-821-0100 | Fax: 212-821-0105 Ms. Nudrat Salik Mr. Terence O’Brien United States Securities and Exchange Commission Office of Industrial Applications and Services Division of Corporation Finance 100 F Street, NE Mail Stop 3030 Washington, D.C. 20549 January 29, 2024 Re: IMAX CORP (“IMAX” or “the Company”) Form 10-K for Fiscal Year Ended December 31, 2022 Form 10-Q for Fiscal Quarter Ended September 30, 2023 File No. 001-3506 |
|
| January 25, 2024 |
EX-7.2 3 d714034dex72.htm EX-7.2 Exhibit 7.2 LIMITED POWER OF ATTORNEY FOR REPORTING OBLIGATIONS UNDER SECTIONS 13(D) AND 13(G) OF THE SECURITIES EXCHANGE ACT OF 1934 The undersigned hereby make, constitute and appoint each of Eileen Wheatman and Kevin Douglas, acting either individually or together, as each of the undersigned’s true and lawful attorneys-in-fact, with full power and authority as h |
|
| January 25, 2024 |
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D EX-7.1 2 d714034dex71.htm EX-7.1 Exhibit 7.1 AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D Each of the undersigned hereby acknowledges and agrees, pursuant to the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13D to which this Agreement is attached as an Exhibit, and any amendments thereto, with respect to the be |
|
| January 25, 2024 |
IMAX / IMAX Corporation / DOUGLAS KEVIN - SC 13D/A Activist Investment SC 13D/A 1 d714034dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8) IMAX Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 45245E109 (CUSIP Number) Ryan J. York Accretive Legal, PLLC 34522 N. Scottsdale Rd. STE 120-113 Scottsdale, AZ 85266 (425) 786-9256 (Name, |
|
| December 19, 2023 |
United States securities and exchange commission logo December 19, 2023 Natasha Fernandes Chief Financial Officer IMAX CORP 902 Broadway, Floor 20 New York, NY 10010 Re: IMAX CORP Form 10-K for Fiscal Year Ended December 31, 2022 Form 10-Q for Fiscal Quarter Ended September 30, 2023 File No. |
|
| October 25, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 October 25, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX C |
|
| October 25, 2023 |
IMAX CORPORATION REPORTS RECORD Q3 2023 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS RECORD Q3 2023 RESULTS • Global entertainment technology platform delivers strong Q3 year-over-year growth across all key financial metrics, including Revenue (+51%), Gross Margin (+98%) and Adjusted EBITDA (+174%)(1) • Network growth accelerates while system signings climb to 120 to-date — more than double what the Company delivered in all of 2022 (47) • Q3 m |
|
| October 6, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) IMAX Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Equity Common Shares, no par value Other(2) 2,900,000(3) $18. |
|
| October 6, 2023 |
As filed with the Securities and Exchange Commission on October 6, 2023 As filed with the Securities and Exchange Commission on October 6, 2023 Registration No. |
|
| July 26, 2023 |
IMAX CORPORATION REPORTS Q2 2023 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS Q2 2023 RESULTS • Global entertainment technology platform delivers strong Q2 year-over-year growth across all key metrics, including Revenue (+32%), Gross Margin (+31%) and Adjusted EBITDA (+29%)(1) • Systems signings climb to 84 to-date — significantly more than the Company delivered in all of 2022 (47) — as system installations grow to 29 through June • Str |
|
| July 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpor |
|
| July 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 26, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 12, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 13, 2023 |
EX-99.1 Exhibit 99.1 IMAX Corporation to Acquire Full Ownership of IMAX China Disclaimer: No statement in this investor presentation should be interpreted to mean that the earnings Ju l y 12 , 20 23 of IMAX Corporation or IMAX China for the current year or future years will necessarily match or exceed the historical or published earnings or financial performance of IMAX Corporation or IMAX China, |
|
| July 13, 2023 |
IMAX Corporation (Incorporated in Canada with limited liability) EX-99.2 Exhibit 99.2 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. This annou |
|
| July 13, 2023 |
EX-99.3 Exhibit 99.3 IMAX Corporation Announces Intent to Acquire Full Ownership of IMAX China Subsidiary Proposed Transaction to Further Enhance Financial Profile of IMAX Corporation while Fueling New Growth Opportunities in China Company to host conference call today at 6:15 p.m. ET to discuss transaction; details available below and at imax.com/content/investor-relations NEW YORK – July 12, 202 |
|
| June 14, 2023 |
IMAX Announces Extension of Current Share-Repurchase Program EX-99.1 Exhibit 99.1 IMAX Announces Extension of Current Share-Repurchase Program NEW YORK, NY— June 14, 2023 – IMAX Corporation (NYSE: IMAX) today announced a 3-year extension to the Company’s share-repurchase program through June 30, 2026. The current share-repurchase program authorized the Company to repurchase up to $400 million of its common shares, of which approximately $191.5 million remai |
|
| June 14, 2023 |
Second Amended and Restated By-Law No. 1 of IMAX Corporation, enacted on February 7, 2023. EX-3.1 Exhibit 3.1 IMAX CORPORATION SECOND AMENDED AND RESTATED BY-LAW NO. 1 FEBRUARY 7, 2023 SECOND AMENDED AND RESTATED BY-LAW NO. 1 IMAX CORPORATION A by-law regulating generally the transaction of the business and affairs of IMAX Corporation. Section 1 INTERPRETATION 1.1 Definitions. In this by-law, which may be cited as the By-law, unless the context otherwise requires: “Act” means the Canada |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 June 8, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| June 14, 2023 |
Amendment No.1 to Second Amended and Restated Long-Term Incentive Plan EX-10.1 Exhibit 10.1 IMAX CORPORATION AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED LONG-TERM INCENTIVE PLAN This Amendment No. 1 (the “Amendment”) to the Second Amended and Restated IMAX Corporation Long Term Incentive Plan (the “Plan”) is made by IMAX Corporation, a Canadian corporation (the “Company”), effective as of the date of its approval by the shareholders of the Company at the Company’s |
|
| May 31, 2023 |
Conflict Minerals Report for the year ended December 31, 2022 Exhibit 1.01 IMAX CORPORATION Conflict Minerals Report For the Year Ended December 31, 2022 This report for the year ended December 31, 2022 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). The Rule was adopted by the Securities and Exchange Commission (the “SEC”) to implement reporting and disclosure requirements related to conflict minerals as direct |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT IMAX Corporation (Exact name of the registrant as specified in its charter) Canada 001-35066 98-0140269 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 2525 Speakman Drive, 902 Broadway, Floor 20 Mississauga, ON, Can |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 27, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 27, 2023 |
IMAX CORPORATION REPORTS Q1 2023 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS Q1 2023 RESULTS • Global entertainment technology platform drives strong year-over-year growth across all key metrics, including Revenue (+45%), Gross Margin (+58%) and Adjusted EBITDA (+84%)(1) • System sales climb to 63 signings year-to-date through April — significantly more than the Company delivered in all of 2022 (47) • Strong global box office performan |
|
| April 27, 2023 |
Letter Agreement by and between Megan Colligan and IMAX Corporation. IMAX CORPORATION Exhibit 10.2 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. March 15, 2023 Via Email Ms. Megan Colligan [***] Dear Megan: I am writing to confirm our agreement with respect to your departure from IMAX Corporat |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpo |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file Number 001-35066 IMAX Corporation (Exact name of registrant as specif |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X ] Definitive |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the appropriate box: [ X] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [ ] Definitive |
|
| March 28, 2023 |
IMAX Historical P&L - Consolidated EX-99.1 Exhibit 99.1 IMAX Historical P&L - Consolidated $ in 000s 2018 2019 2019 2020 2020 2021 2021 2022 2022 Actuals Actuals Actuals Actuals Actuals FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY IMAX Global Box Office 1,032,153 256,300 364,932 246,054 241,165 1,108,513 95,226 2,658 70,358 90,979 259,220 110,231 108,558 141,893 277,534 638,216 173,183 247,900 177,097 251,545 849, |
|
| March 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 March 28, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 March 13, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 6, 2023 |
EX-99.1 Exhibit 99.1 IMAX NAMES GAIL BERMAN AND JEN WONG TO BOARD OF DIRECTORS Award-Winning Entertainment Executive Berman Brings Decades of Experience across Film, Television, Digital, and Broadway Currently Chief Operating Officer of Reddit, Wong has Led Strategy and Growth for Leading Global Media Brands NEW YORK — March 6, 2023 — IMAX Corporation (NYSE: IMAX) today announced two new appointme |
|
| March 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 March 6, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| February 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 February 22, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| February 22, 2023 |
IMAX CORPORATION REPORTS Q4 AND FULL-YEAR 2022 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS Q4 AND FULL-YEAR 2022 RESULTS • IMAX expects return to pre-pandemic gross box office level of $1.1 billion in 2023 as year begins with strong reopening of China and record-breaking performance of “Avatar: The Way of Water” of approximately $250 million in global box office • IMAX drives record-breaking Chinese New Year box office of $61.3 million in 2023, led |
|
| February 22, 2023 |
Power of Attorney of certain directors. IMAX CORPORATION EXHIBIT 24.1 POWER OF ATTORNEY Each of the persons whose signature appears below hereby constitutes and appoints Natasha Fernandes and Robert D. Lister, and each of them severally, as his true and lawful attorney or attorneys with power of substitution and re-substitution to sign in his name, place and stead in any and all such capacities the Form 10-K, including the French langua |
|
| February 22, 2023 |
Subsidiaries of IMAX Corporation. IMAX CORPORATION Exhibit 21.1 SUBSIDIARIES OF IMAX CORPORATION Company Name Place of Incorporation Percentage Held - Indirect 3183 Films Ltd. Canada 100 12582 Productions Inc. Delaware 100 1329507 Ontario Inc. Ontario 100 2328764 Ontario Ltd. Ontario 100 4507592 Canada Ltd. Canada 100 6822967 Canada Ltd. Canada 100 7096267 Canada Ltd. Canada 100 7103077 Canada Ltd. Canada 100 7109857 Canada Ltd. C |
|
| February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 February 22, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file Number 001-35066 IMAX Corporation (Exact name of registrant as specif |
|
| February 22, 2023 |
Statement of Directors’ Compensation as of January 2023. Exhibit 10.37 IMAX CORPORATION Summary of Directors’ Compensation as of January 2023 All dollar amounts in this summary are expressed in United States Dollars. 1. In respect of each year during which an independent Director serves as a Director of IMAX Corporation, such Director shall receive: a. $50,000 per year payable quarterly, in arrears; b. at the commencement of each year of office or upon |
|
| February 14, 2023 |
IMAX / Imax Corp. / GELFOND RICHARD L - SC 13G/A Passive Investment SC 13G/A 1 d205516dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * IMAX CORPORATION (Name of Issuer) Common Shares (Title of Class of Securities) 45245E109 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 14, 2023 |
IMAX / Imax Corp. / Nantahala Capital Management, LLC - SC 13G/A Passive Investment SC 13G/A 1 tm236168d14sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* IMAX Corporation (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 45245E109 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriat |
|
| February 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 February 7, 2023 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 10, 2023 |
Second Amended and Restated By-Law No. 1 of IMAX Corporation, enacted on February 7, 2023. EX-3.1 Exhibit 3.1 IMAX CORPORATION SECOND AMENDED AND RESTATED BY-LAW NO. 1 FEBRUARY 7, 2023 SECOND AMENDED AND RESTATED BY-LAW NO. 1 IMAX CORPORATION A by-law regulating generally the transaction of the business and affairs of IMAX Corporation. Section 1 INTERPRETATION 1.1 Definitions. In this by-law, which may be cited as the By-law, unless the context otherwise requires: “Act” means the Canada |
|
| February 9, 2023 |
IMAX / Imax Corp. / FMR LLC Passive Investment SC 13G 1 filing.txt SCHEDULE 13G Amendment No.0 IMAX CORPORATION COMMON STOCK Cusip #45245E109 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #45245E109 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 3,262,394 Item 6: 0 Item 7: 3,263,302 Item 8: 0 Item 9: 3,26 |
|
| January 31, 2023 |
IMAX / Imax Corp. / DOUGLAS KEVIN - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) IMAX Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 45245E109 (CUSIP Number) Ryan J. York Accretive Legal, PLLC 34522 N. Scottsdale Rd. STE 120-113 Scottsdale, AZ 85266 (425) 786-9256 (Name, Address and Telephone Number |
|
| January 31, 2023 |
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D EX-7.1 Exhibit 7.1 AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D Each of the undersigned hereby acknowledges and agrees, pursuant to the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13D to which this Agreement is attached as an Exhibit, and any amendments thereto, with respect to the beneficial ownership of the |
|
| January 31, 2023 |
EX-7.2 Exhibit 7.2 LIMITED POWER OF ATTORNEY FOR REPORTING OBLIGATIONS UNDER SECTIONS 13(D) AND 13(G) OF THE SECURITIES EXCHANGE ACT OF 1934 The undersigned hereby make, constitute and appoint each of Eileen Wheatman and Kevin Douglas, acting either individually or together, as each of the undersigned’s true and lawful attorneys-in-fact, with full power and authority as hereinafter described on be |
|
| December 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 December 6, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 31, 2022 |
IMAX CORPORATION REPORTS THIRD QUARTER 2022 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS THIRD QUARTER 2022 RESULTS ? IMAX global entertainment technology platform drives double-digit growth across Revenue, Gross Margin and Adjusted EBITDA as well as positive Net Income within IMAX China ? Total IMAX Gross Box Office increased 25% year over year to $177.1 million, with 30% of box office coming from Local Language blockbusters ? Strong upcoming blo |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX C |
|
| October 31, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 October 31, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 31, 2022 |
Execution Version IMAX CORPORATION Exhibit 10.1 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT This agreement (this "Second Amendment") amends, effective as of January 1, 2023 (the Effective Date"), the employment agreement between Richard L. Gelfond (the "Executive") and IMAX Corporation (the "Company"), dated November 8, 2016, as amended effective January 1, 2020 (the ?First Amendment?), (together, th |
|
| September 22, 2022 |
Exhibit 99.2 S S I M W A V E A C Q U I S I T I O N / S T R A T E G I C U P D A T E S E P T E M B E R 2 0 2 2 F O R W A R D - L O O K I N G S T A T E M E N T S This strategic update contains forward looking statements that are based onIMAX management?s assumptions on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update and existing information and involve cer |
|
| September 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 September 22, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| September 22, 2022 |
Exhibit 99.1 IMAX Acquires Streaming Technology Company SSIMWAVE Inc. Breakthrough AI-Driven Software and IP to Expand IMAX Image Enhancement Capabilities and Drive New Revenue Across All Video Platforms NEW YORK and ONTARIO ? September 22, 2022 ? IMAX Corporation (NYSE: IMAX) today announced it has acquired SSIMWAVE Inc., a leader in AI-driven video quality solutions for media and entertainment c |
|
| September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 September 19, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| September 7, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 September 7, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| September 7, 2022 |
IMAX Announces $200 Million Increase to Current Share-Repurchase Program Exhibit 99.1 IMAX Announces $200 Million Increase to Current Share-Repurchase Program NEW YORK, NY? September 7, 2022 ? IMAX Corporation (NYSE: IMAX) today announced an increase of $200 million in the Company?s share-repurchase program, bringing the Company?s total share repurchase authority to $400 million. The Company has repurchased a total of approximately 10.0 million of its common shares (or |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpor |
|
| July 29, 2022 |
Employment Agreement, dated April 25, 2022, between IMAX Corporation and Natasha Fernandes. IMAX CORPORATION Exhibit 10.1 April 25, 2022 Strictly Private & Confidential Natasha Fernandes 154 Summerfield Dr Oakville, ON L6L 5N8 Dear Natasha, We are pleased to provide you with the details of your promotion below: Job Title: Executive Vice President, Chief Financial Officer Reporting to: Rich Gelfond, CEO Effective Date: May 1, 2022 Base Salary: $460,161.37 CAD per annum. We will also guara |
|
| July 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 28, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 28, 2022 |
IMAX CORPORATION REPORTS SECOND QUARTER 2022 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS SECOND QUARTER 2022 RESULTS ? Strong Year-Over-Year Growth across Key Metrics Underscores Company?s Position as a Premier Global Technology Platform for Entertainment and Events ? Global Box Office of $247.7 Million (+128.1% YoY) Driven by ?Top Gun: Maverick?, "Doctor Strange in the Multiverse of Madness? and ?Jurassic World Dominion? as Dramatic Surge in Movi |
|
| June 30, 2022 |
IMAX Announces Extension of Current Share-Repurchase Program Exhibit 99.1 IMAX Announces Extension of Current Share-Repurchase Program NEW YORK, NY? June 30, 2022 ? IMAX Corporation (NYSE: IMAX) today announced a 12-month extension to the Company?s share-repurchase program through June 30, 2023. The current share-repurchase program authorized the Company to repurchase up to $200 million of its common shares, of which approximately $26.2 million remains avai |
|
| June 30, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 June 30, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 10, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 June 9, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 31, 2022 |
Conflict Minerals Report for the year ended December 31, 2021 Exhibit 1.01 IMAX CORPORATION Conflict Minerals Report For the Year Ended December 31, 2021 This report for the year ended December 31, 2021 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?Rule?). The Rule was adopted by the Securities and Exchange Commission (the ?SEC?) to implement reporting and disclosure requirements related to conflict minerals as direct |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT IMAX Corporation (Exact name of the registrant as specified in its charter) Canada 001-35066 98-0140269 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 2525 Speakman Drive, 902 Broadway, Floor 20 Mississauga, ON, Can |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 19, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (C |
|
| April 28, 2022 |
IMAX CORPORATION REPORTS FIRST QUARTER 2022 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS FIRST QUARTER 2022 RESULTS ? Strong Year-Over-Year Growth in Key Metrics Underscore Company?s Position as a Premier Global Technology Platform for Entertainment and Events ? Global Box Office of $173.2 Million (+57% YoY) Driven by Strong Performances of ?The Batman? and ?Spider-Man: No Way Home? ? IMAX Continues Strong Market Share Gains of 2021, Capturing 4.7 |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpo |
|
| April 28, 2022 |
Execution Copy IMAX CORPORATION Exhibit 10.1 SIXTH AMENDED AND RESTATED CREDIT AGREEMENT by and between IMAX CORPORATION, as Borrower - and - THE GUARANTORS REFERRED TO HEREIN, as Guarantors - and - THE LENDERS REFERRED TO HEREIN, as Lenders - and - WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, Issuing Lender and Swingline Lender - and - WELLS FARGO SECURITIES, LLC, as Sole Lead |
|
| April 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 28, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X ] Definitive |
|
| April 19, 2022 |
Exhibit 99.1 IMAX Promotes Natasha Fernandes to Chief Financial Officer Longtime Company Executive to Oversee Finance across Global Operations NEW YORK, NY ? April 19, 2022 ? IMAX Corporation (NYSE: IMAX) today announced it is promoting Natasha Fernandes to the role of Chief Financial Officer (CFO), effective May 1. A 15-year veteran of the Company?s Finance team, Fernandes most recently served as |
|
| April 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 19, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 March 25, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| February 24, 2022 |
IMAX CORPORATION Exhibit 21.1 SUBSIDIARIES OF IMAX CORPORATION Company Name Place of Incorporation Percentage Held - Indirect 3183 Films Ltd. Canada 100 12582 Productions Inc. Delaware 100 1329507 Ontario Inc. Ontario 100 2328764 Ontario Ltd. Ontario 100 4507592 Canada Ltd. Canada 100 6822967 Canada Ltd. Canada 100 7096267 Canada Ltd. Canada 100 7103077 Canada Ltd. Canada 100 7109857 Canada Ltd. C |
|
| February 24, 2022 |
Fourth Amendment to the Fifth Amended and Restated Credit Agreement, dated as of December 13, 2021 Execution Copy IMAX CORPORATION Exhibit 10.46 FOURTH AMENDMENT TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT FOURTH AMENDMENT TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT (this ?Amendment?), dated as of December 13, 2021, among IMAX CORPORATION, a corporation incorporated pursuant to the laws of Canada (the ?Borrower?), the Guarantors (as defined in the Credit Agreement referred to below) party |
|
| February 24, 2022 |
IMAX CORPORATION Exhibit 10.38 Memorandum To: MARK WELTON from: JACKI BASSANI cc: RICH GELFOND Date: October 13, 2021 Subject: amendment to September 18, 2020 EMPLOYMENT TERMS memorandum I am writing to confirm the amendment we are making to the September 18, 2020 Memorandum that documents the terms and conditions of your ongoing employment (the ?Memorandum?). The ?Vacation and Benefits? provision |
|
| February 24, 2022 |
IMAX CORPORATION EXHIBIT 24.1 POWER OF ATTORNEY Each of the persons whose signature appears below hereby constitutes and appoints Joseph Sparacio and Robert D. Lister, and each of them severally, as his true and lawful attorney or attorneys with power of substitution and re-substitution to sign in his name, place and stead in any and all such capacities the Form 10-K, including the French language |
|
| February 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file Number 001-35066 IMAX Corporation (Exact name of registrant as specif |
|
| February 23, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 February 23, 2022 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| February 23, 2022 |
IMAX CORPORATION REPORTS Q4 AND FULL-YEAR 2021 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS Q4 AND FULL-YEAR 2021 RESULTS ? Strongest Quarterly Revenue, Operating Income, and Earnings Per Share since 2019 Underscore Company?s Position as a Premier Global Technology Platform for Entertainment and Events ? Full-Year 2021 Results Demonstrate Strong Momentum, with 146% Growth in Global Box Office, as IMAX Captures its Highest Share Ever of Yearly Global |
|
| February 14, 2022 |
IMAX / Imax Corp. / Nantahala Capital Management, LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* IMAX Corporation (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 45245E109 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| February 11, 2022 |
IMAX / Imax Corp. / GELFOND RICHARD L - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 IMAX CORPORATION (Name of Issuer) Common Shares (Title of Class of Securities) 45245E109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ?: Ru |
|
| January 31, 2022 |
IMAX / Imax Corp. / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* IMAX Corp (Name of Issuer) Common Stock (Title of Class of Securities) 45245E109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| January 27, 2022 |
IMAX / Imax Corp. / DOUGLAS KEVIN - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) IMAX Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 45245E109 (CUSIP Number) Ryan J. York Accretive Legal, PLLC 34522 N. Scottsdale Rd. STE 120-113 Scottsdale, AZ 85266 (425) 786-9256 (Name, Address and Telephone Number of Person |
|
| October 28, 2021 |
IMAX CORPORATION REPORTS THIRD QUARTER 2021 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS THIRD QUARTER 2021 RESULTS HIGHLIGHTS ? IMAX reaches turning point at global box office ? breaking record for highest grossing month of October, delivering September grosses above 2019, and generating $142 million (+100% YoY) in Global Box Office for the Third Quarter ? The Company delivers strongest Global Box Office, Revenue, and Gross Margin since 2019, wit |
|
| October 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX C |
|
| October 28, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 October 28, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| August 18, 2021 |
As filed with the Securities and Exchange Commission on August 18, 2021 As filed with the Securities and Exchange Commission on August 18, 2021 Registration No. |
|
| August 18, 2021 |
As filed with the Securities and Exchange Commission on August 18, 2021 As filed with the Securities and Exchange Commission on August 18, 2021 Registration No. |
|
| August 18, 2021 |
As filed with the Securities and Exchange Commission on August 18, 2021 As filed with the Securities and Exchange Commission on August 18, 2021 Registration No. |
|
| August 18, 2021 |
As filed with the Securities and Exchange Commission on August 18, 2021 As filed with the Securities and Exchange Commission on August 18, 2021 Registration No. |
|
| August 18, 2021 |
As filed with the Securities and Exchange Commission on August 18, 2021 As filed with the Securities and Exchange Commission on August 18, 2021 Registration No. |
|
| August 18, 2021 |
As filed with the Securities and Exchange Commission on August 18, 2021 As filed with the Securities and Exchange Commission on August 18, 2021 Registration No. |
|
| July 29, 2021 |
Third Amendment to the Fifth Amended and Restated Credit Agreement, dated as of July 28, 2021. Exhibit 10.1 EXECUTION COPY THIRD AMENDMENT TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT THIRD AMENDMENT TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT (this ?Amendment?), dated as of July 28, 2021, among IMAX CORPORATION, a corporation incorporated pursuant to the laws of Canada (the ?Borrower?), the Guarantors (as defined in the Credit Agreement referred to below) party hereto, each of the Len |
|
| July 29, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 28, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 27, 2021 |
Amended and Restated By-Law No. 1 of IMAX Corporation, enacted on March 4, 2021. EXHIBIT 3.1 Imax Corporation AMENDED AND RESTATED By-Law No. 1 March 4, 2021 AMENDED AND RESTATED BY-LAW NO. 1 IMAX CORPORATION A by-law regulating generally the transaction of the business and affairs of IMAX Corporation. Section 1 INTERPRETATION 1.1 Definitions. In this by-law, which may be cited as the By-law, unless the context otherwise requires: ?Act? means the Canada Business Corporations A |
|
| July 27, 2021 |
IMAX CORPORATION REPORTS SECOND QUARTER 2021 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS SECOND QUARTER 2021 RESULTS HIGHLIGHTS ? IMAX delivered strong year-over-year growth in Total Revenue and Global Box Office, driven by the initial return of Hollywood blockbuster releases and a significant rebound in the domestic box office ? The Company continued to improve its operating results, reporting its best Gross Margin of the pandemic era, and third |
|
| July 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpor |
|
| July 27, 2021 |
Offer Letter, effective May 14, 2021, between IMAX Corporation and Joseph Sparacio EXHIBIT 10.1 April 28, 2021 Approved by the Compensation Committee and effective as of May 14, 2021 Strictly Private & Confidential Joseph Sparacio [email protected] Dear Joe, I am writing to confirm our agreement with respect to your service as Interim Chief Financial Officer of IMAX Corporation ("IMAX" or the "Company"). We have agreed as follows: Title:Interim Chief Financial Officer Reporting |
|
| July 27, 2021 |
Exhibit 10.2 IMAX CORPORATION SECOND AMENDED AND RESTATED LONG-TERM INCENTIVE PLAN RESTRICTED SHARE UNIT AWARD AGREEMENT FOR NON-EMPLOYEE DIRECTOR THIS RESTRICTED SHARE UNIT AGREEMENT (the ?Agreement?) is made effective as of June 10, 2021 (the ?Date of Grant?) between IMAX Corporation, a Canadian corporation (the ?Company?), and [Director name] (the ?Participant?). This Agreement sets forth the g |
|
| July 27, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 27, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 25, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 June 25, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 25, 2021 |
IMAX Announces Extension of Current Share-Repurchase Program EXHIBIT 99.1 IMAX Announces Extension of Current Share-Repurchase Program NEW YORK, NY? June 25, 2021 ? IMAX Corporation (NYSE: IMAX) today announced a 12-month extension to the Company?s share-repurchase program through June 30, 2022. The current share-repurchase program authorized the Company to repurchase up to $200 million of its common shares, of which approximately $89.4 million remains avai |
|
| June 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 June 9, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| June 10, 2021 |
IMAX CORPORATION Exhibit 99.1 DARREN THROOP ELECTED CHAIRMAN OF IMAX BOARD OF DIRECTORS, VETERAN ENTERTAINMENT EXECUTIVE STEVE PAMON TO JOIN IMAX BOARD Throop ? Founder, CEO and President of Entertainment One ? has Served on IMAX Board since 2015 Pamon Brings Decades of Experience in Media and Entertainment, Most Recently as President and COO of Beyonc??s Parkwood Entertainment NEW YORK ? June 9, |
|
| June 1, 2021 |
Conflict Minerals Report for the year ended December 31, 2020 Exhibit 1.01 IMAX CORPORATION Conflict Minerals Report For the Year Ended December 31, 2020 This report for the year ended December 31, 2020 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?Rule?). The Rule was adopted by the Securities and Exchange Commission (the ?SEC?) to implement reporting and disclosure requirements related to conflict minerals as direct |
|
| June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT IMAX Corporation (Exact name of the registrant as specified in its charter) Canada 001-35066 98-0140269 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 2525 Speakman Drive, 902 Broadway, Floor 20 Mississauga, ON, Can |
|
| May 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 May 14, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| April 29, 2021 |
Exhibit 10.12 IMAX CORPORATION SECOND AMENDED AND RESTATED LONG-TERM INCENTIVE PLAN PERFORMANCE STOCK UNIT AWARD AGREEMENT THIS PERFORMANCE STOCK UNIT AWARD AGREEMENT (the ?Agreement?) is made effective as of (the ?Date of Grant?) between IMAX Corporation, a Canadian corporation (the ?Company?), and (the ?Participant?). This Agreement sets forth the general terms and conditions of performance stoc |
|
| April 29, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 29, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 29, 2021 |
IMAX CORPORATION REPORTS FIRST QUARTER 2021 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS FIRST QUARTER 2021 RESULTS HIGHLIGHTS ? IMAX continues to help lead the global film industry out of the pandemic as pent-up demand emerges in global markets driving year-over-year quarterly growth in revenue, box office, gross margins and EBITDA ? Company posts $110 million in global box office ? its first year-over-year quarterly box office growth of the pand |
|
| April 29, 2021 |
IMAX CORPORATION Exhibit 10.10 March 30, 2021 VIA EMAIL To: Bradley J. Wechsler Re: Your Service as Chairman of the Board of Directors Dear Brad: I am writing to confirm our agreement with respect to your service as Chairman of the Board of Directors of IMAX Corporation (?IMAX? or the ?Company?). We have agreed as follows: 1. You have notified the Company that you will step down as Chairman of the |
|
| April 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35066 IMAX Corpo |
|
| April 29, 2021 |
Exhibit 10.11 IMAX CORPORATION SECOND AMENDED AND RESTATED LONG-TERM INCENTIVE PLAN RESTRICTED SHARE UNIT AWARD AGREEMENT THIS RESTRICTED SHARE UNIT AGREEMENT (the ?Agreement?) is made effective as of (the ?Date of Grant?) between IMAX Corporation, a Canadian corporation (the ?Company?), and (the ?Participant?). This Agreement sets forth the general terms and conditions of Restricted Share Units ( |
|
| April 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X] Definitive P |
|
| April 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the appropriate box: [X ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [ ] Definitive |
|
| April 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 15, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 30, 2021 |
BRAD WECHSLER TO STEP DOWN AS CHAIRMAN OF IMAX CORPORATION Exhibit 99.1 BRAD WECHSLER TO STEP DOWN AS CHAIRMAN OF IMAX CORPORATION NEW YORK, NY? March 30, 2021 ? IMAX Corporation (NYSE: IMAX) today announced that Bradley Wechsler has notified the Company he will step down as Chairman of the Board of IMAX at the Company?s annual shareholders meeting (AGM) on June 9, 2021, after nearly 30 years of service to the Company. IMAX?s Board of Directors will selec |
|
| March 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 March 30, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 19, 2021 |
Exhibit 10.3 Execution Version JPMorgan Chase Bank, National Association New York Branch 383 Madison Avenue New York, NY 10179 March 16, 2021 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Vice-President, Finance & Corporate Treasurer Telephone No.: (905) 403-6457 Email: [email protected]; [email protected] Re: Base Call Option Transa |
|
| March 19, 2021 |
Second Amendment to the Fifth Amended and Restated Credit Agreement entered into on March 15, 2021. Exhibit 10.9 EXECUTION VERSION SECOND AMENDMENT TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT SECOND AMENDMENT TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT (this ?Amendment?), dated as of March 15, 2021, among IMAX CORPORATION, a corporation incorporated pursuant to the laws of Canada (the ?Borrower?), the Guarantors (as defined in the Credit Agreement referred to below) party hereto, each of t |
|
| March 19, 2021 |
Exhibit 10.1 Execution Version Wells Fargo Bank, National Association 30 Hudson Yards New York, NY 10001-2170 Email: [email protected] March 16, 2021 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Vice-President, Finance & Corporate Treasurer Telephone No.: (905) 403-6457 Email: [email protected]; KWeissma |
|
| March 19, 2021 |
Indenture, dated as of March 19, 2021, between IMAX Corporation and U.S. Bank National Association. Exhibit 4.1 IMAX CORPORATION and U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of March 19, 2021 0.500% Convertible Senior Notes due 2026 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction 1 Section 1.01. Definitions 1 Section 1.02. Other Definitions 13 Section 1.03. Rules of Construction 13 Article 2. The Notes 14 Section 2.01. Form, Dating and Denominations 14 Se |
|
| March 19, 2021 |
IMAX Corporation Prices $200 Million Convertible Senior Notes Offering Exhibit 99.2 IMAX Corporation Prices $200 Million Convertible Senior Notes Offering New York?March 16, 2021?IMAX Corporation (NYSE: IMAX) (?IMAX?) today announced the pricing of $200,000,000 aggregate principal amount of 0.500% convertible senior notes due 2026 (the ?notes?) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended ( |
|
| March 19, 2021 |
IMAX Corporation Announces Proposed Convertible Senior Notes Offering Exhibit 99.1 IMAX Corporation Announces Proposed Convertible Senior Notes Offering New York?March 15, 2021?IMAX Corporation (NYSE: IMAX) (?IMAX?) today announced its intention to offer, subject to market and other conditions, $200,000,000 aggregate principal amount of convertible senior notes due 2026 (the ?notes?) in a private offering to qualified institutional buyers pursuant to Rule 144A under |
|
| March 19, 2021 |
Exhibit 10.6 Mizuho Markets Americas LLC c/o Mizuho Securities USA LLC, as agent 1271 Avenue of the Americas New York, NY 10020 March 18, 2021 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Vice-President, Finance & Corporate Treasurer Telephone No.: (905) 403-6457 Email: [email protected]; [email protected] Re: Additional Call Option |
|
| March 19, 2021 |
Exhibit 10.4 HSBC Bank USA, National Association 452 Fifth Avenue New York, NY 10018 March 16, 2021 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Vice-President, Finance & Corporate Treasurer Telephone No.: (905) 403-6457 Email: [email protected]; [email protected] Re: Base Call Option Transaction The purpose of this letter agreement |
|
| March 19, 2021 |
Exhibit 10.8 HSBC Bank USA, National Association 452 Fifth Avenue New York, NY 10018 March 18, 2021 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Vice-President, Finance & Corporate Treasurer Telephone No.: (905) 403-6457 Email: [email protected]; [email protected] Re: Additional Call Option Transaction The purpose of this letter agr |
|
| March 19, 2021 |
Exhibit 10.7 JPMorgan Chase Bank, National Association New York Branch 383 Madison Avenue New York, NY 10179 March 18, 2021 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Vice-President, Finance & Corporate Treasurer Telephone No.: (905) 403-6457 Email: [email protected]; [email protected] Re: Additional Call Option Transaction The pu |
|
| March 19, 2021 |
Exhibit 10.5 Wells Fargo Bank, National Association 30 Hudson Yards New York, NY 10001-2170 Email: [email protected] March 18, 2021 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Vice-President, Finance & Corporate Treasurer Telephone No.: (905) 403-6457 Email: [email protected]; [email protected] Re: Add |
|
| March 19, 2021 |
Exhibit 10.2 Execution Version Mizuho Markets Americas LLC c/o Mizuho Securities USA LLC, as agent 1271 Avenue of the Americas New York, NY 10020 March 16, 2021 To: IMAX Corporation 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 Attention: Natasha Fernandes, Vice-President, Finance & Corporate Treasurer Telephone No.: (905) 403-6457 Email: [email protected]; [email protected] Re: Base |
|
| March 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 March 15, 2021 Date of report (Date of earliest event reported): IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| March 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| March 4, 2021 |
Amended and Restated By-Law No. 1 of IMAX Corporation, enacted on March 4, 2021. EXHIBIT 3.2 Imax Corporation AMENDED AND RESTATED By-Law No. 1 March 4, 2021 AMENDED AND RESTATED BY-LAW NO. 1 IMAX CORPORATION A by-law regulating generally the transaction of the business and affairs of IMAX Corporation. Section 1 INTERPRETATION 1.1 Definitions. In this by-law, which may be cited as the By-law, unless the context otherwise requires: ?Act? means the Canada Business Corporations A |
|
| March 4, 2021 |
IMAX CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS Exhibit 99.1 IMAX CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS HIGHLIGHTS ? Strong box office across Asia drove IMAX results, offering encouraging signs of pent-up demand among global audiences with a robust Hollywood slate scheduled ahead ? IMAX posted another quarter of sequential improvement in key financial metrics, validating the Company?s superior asset-light business model |
|
| March 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 March 4, 2021 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| March 4, 2021 |
Subsidiaries of IMAX Corporation. IMAX CORPORATION Exhibit 21 SUBSIDIARIES OF IMAX CORPORATION Company Name Place of Incorporation Percentage Held - Indirect 3183 Films Ltd. |
|
| March 4, 2021 |
Statement of Directors’ Compensation, dated January 12, 2021. IMAX CORPORATION Exhibit 10.43 Summary of Directors? Compensation 1. In respect of each year during which an independent Director serves as a Director of the Corporation, such Director shall receive: a. $50,000 (US) per year payable quarterly in arrears; b. at the commencement of each year of office or upon joining the Board, or as soon as practicable thereafter, a grant of RSUs with an aggregate |
|
| March 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file Number 001-35066 IMAX Corporation (Exact name of registrant as specif |
